Abstract
Objectives
The study investigated the role of myocardial suppressor of cytokine signaling-3 (SOCS3), an intrinsic negative feedback regulator of the janus kinase and signal transducer and activator of transcription (JAK-STAT) signaling pathway, in the development of left ventricular (LV) remodeling after acute myocardial infarction (AMI).Background
LV remodeling after AMI results in poor cardiac performance leading to heart failure. Although it has been shown that JAK-STAT-activating cytokines prevent LV remodeling after AMI in animals, little is known about the role of SOCS3 in this process.Methods
Cardiac-specific SOCS3 knockout mice (SOCS3-CKO) were generated and subjected to AMI induced by permanent ligation of the left anterior descending coronary artery.Results
Although the initial infarct size after coronary occlusion measured by triphenyltetrazolium chloride staining was comparable between SOCS3-CKO and control mice, the infarct size 14 days after AMI was remarkably inhibited in SOCS3-CKO, indicating that progression of LV remodeling after AMI was prevented in SOCS3-CKO hearts. Prompt and marked up-regulations of multiple JAK-STAT-activating cytokines including leukemia inhibitory factor and granulocyte colony-stimulating factor (G-CSF) were observed within the heart following AMI. Cardiac-specific SOCS3 deletion enhanced multiple cardioprotective signaling pathways including STAT3, AKT, and extracellular signal-regulated kinase (ERK)-1/2, while inhibiting myocardial apoptosis and fibrosis as well as augmenting antioxidant expression.Conclusions
Enhanced activation of cardioprotective signaling pathways by inhibiting myocardial SOCS3 expression prevented LV remodeling after AMI. Our data suggest that myocardial SOCS3 may be a key molecule in the development of LV remodeling after AMI.References
Articles referenced by this article (43)
Novel pharmacotherapies to abrogate postinfarction ventricular remodeling.
Nat Rev Cardiol, (4):283-291 2009
MED: 19352332
Mechanisms and models in heart failure: A combinatorial approach.
Circulation, (9):999-1008 1999
MED: 10468532
Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.
Circulation, (25):2981-2988 2000
MED: 10869273
Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.
Circulation, (25):2727-2735 2010
MED: 21173361
G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
Nat Med, (3):305-311 2005
MED: 15723072
Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Circulation, (21):2572-2580 2004
MED: 15123535
Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice.
J Clin Invest, (6):2016-2029 2010
MED: 20484812
Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Cardiovasc Res, (3):466-477 2006
MED: 16781691
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
J Am Coll Cardiol, (1):176-184 2006
MED: 16814664
Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Circulation, (5):684-691 2010
MED: 20100971
Show 10 more references (10 of 43)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.jacc.2011.10.887
Article citations
Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma-Benefit of MAO-A Inhibition for Cardiac Cachexia.
Biomedicines, 12(9):2009, 03 Sep 2024
Cited by: 0 articles | PMID: 39335522 | PMCID: PMC11428447
Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin.
Int J Mol Sci, 25(2):1137, 17 Jan 2024
Cited by: 0 articles | PMID: 38256208 | PMCID: PMC10816997
Review Free full text in Europe PMC
SOCS3, Transcriptionally Activated by NR4A1, Induces Apoptosis and Extracellular Matrix Degradation of Vaginal Fibroblasts in Pelvic Organ Prolapse
Balkan Med J, 41(2):105-112, 17 Jan 2024
Cited by: 0 articles | PMID: 38229336 | PMCID: PMC10913121
DNA Methylation and Telomeres-Their Impact on the Occurrence of Atrial Fibrillation during Cardiac Aging.
Int J Mol Sci, 24(21):15699, 28 Oct 2023
Cited by: 4 articles | PMID: 37958686 | PMCID: PMC10650750
Review Free full text in Europe PMC
Endogenous interleukin-22 prevents cardiac rupture after myocardial infarction in mice.
PLoS One, 18(6):e0286907, 15 Jun 2023
Cited by: 2 articles | PMID: 37319277 | PMCID: PMC10270598
Go to all (49) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules.
PLoS One, 10(5):e0127942, 26 May 2015
Cited by: 17 articles | PMID: 26010537 | PMCID: PMC4444323
Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
Am J Physiol Heart Circ Physiol, 311(2):H445-52, 10 Jun 2016
Cited by: 16 articles | PMID: 27288435 | PMCID: PMC5005283
SOCS3: A novel therapeutic target for cardioprotection.
JAKSTAT, 1(4):234-240, 01 Oct 2012
Cited by: 20 articles | PMID: 24058778 | PMCID: PMC3670279
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Ministry of Education, Science, Sports, Culture, and Technology
Mochida Memorial Foundation
NHLBI NIH HHS (4)
Grant ID: R01 HL092116-02
Grant ID: R01 HL092116-03
Grant ID: R01 HL092116-01A2
Grant ID: R01 HL092116